Search results
Found 9 matches for
Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PANORAMIC trial of COVID-19 treatments.
PANORAMIC trial finds molnupiravir does not reduce COVID-19 hospitalisation/deaths in vaccinated people at high risk
Research Results
22 December 2022
Researchers from the University of Oxford have today released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial.
New antiviral, Paxlovid, added to PANORAMIC study
General New medications Research
12 April 2022
From today, the antiviral treatment Paxlovid has been included in the national PANORAMIC study, the UK’s fastest ever recruiting clinical trial of its kind, run by the Nuffield Department of Primary Care Health Sciences and supported by the National Institute for Health and Care research (NIHR).
Covid 19: Anti-viral drug study open to patients in NI
General Recruitment Research
8 March 2022
New Story from the BBC: People in Northern Ireland are being urged to take part in a study which will help decide how antiviral drugs will be used to treat Covid-19.
BBC: Patients wanted for Oxford and Southampton Unis' take-at-home pill trial
General Recruitment Research
14 February 2022
Researchers studying the use of an antiviral drug people can take at home to treat Covid want thousands more volunteers to join their trial. Scientists at Oxford and Southampton Universities are looking at how molnupiravir can reduce symptoms in people at risk of serious illness. They have signed up 8,000 recently diagnosed with the virus but want thousands more to join the trial.
BBC Inside Health (Radio 4): PANORAMIC and anti-virals featured
General Research
19 January 2022
BBC Inside Health speak to Nerys from North Wales who has started antiviral treatment for her COVID-19 infection. They also explore the new drugs with virologist Dr Elisabetta Groppelli and Professor Chris Butler who is running the clinical trial designed to pinpoint who is likely to benefit from antivirals the most. (Skip to 15min in for anti-virals).
The Guardian: How antivirals provide hope to vulnerable COVID-19 patients
General Research
18 January 2022
The recent decision by regulators to approve the antiviral agent Paxlovid for use in the UK adds a formidable new weapon to the arsenal of treatments for COVID-19.
New Scientist: UK has begun using drugs for covid-19 cases before they become severe
General Research
18 January 2022
Treatments like sotrovimab, molnupiravir and Paxlovid could lead to a new strategy in 2022: tackling COVID-19 soon after infection to prevent severe symptoms from developing
BBC: Hundreds in Wales take antiviral tablets
General Research
13 January 2022
A news story from the BBC features people taking part in PANORAMIC from Wales
Recruitment begins for national community COVID-19 antiviral trial
General Recruitment Research
8 December 2021
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.